市場調査レポート
商品コード
1494338

北米の経腸栄養剤市場：2030年までの予測、地域別分析 - 製品タイプ別、用途別、年齢層別、流通チャネル別

North America Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel
表紙：北米の経腸栄養剤市場：2030年までの予測、地域別分析 - 製品タイプ別、用途別、年齢層別、流通チャネル別

出版日
ページ情報
英文 114 Pages
納期
即納可能
北米の経腸栄養剤市場：2030年までの予測、地域別分析 - 製品タイプ別、用途別、年齢層別、流通チャネル別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 114 Pages
納期: 即納可能
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

北米の経腸栄養剤市場は、2022年に32億658万米ドルと評価され、2030年には51億8,748万米ドルに達し、2022年から2030年までのCAGRは6.2%で成長すると予測されています。

消化器疾患の増加が北米の経腸栄養剤市場を後押し

消化管疾患には、クローン病、腸閉塞、潰瘍性大腸炎、短腸症候群、顕微鏡的大腸炎、特定のがん種などが含まれます。Global Burden of Disease Study 2019によると、炎症性腸疾患（IBD）の490万症例が2019年に世界で記録され、米国の症例数（762,890人）が最も多く、人口10万人当たりの有病率はそれぞれ66.9人と245.3人でした。クローン病は、主に消化器系に影響を及ぼす複雑な慢性疾患です。さらに、短腸症候群（SBS）は年間100万人あたり3人に発症します。短腸症候群を理解する：2020年に発表された"Understanding Short Bowel Syndrome：Current Status and Future Perspectives "によると、SBSの有病率は過去40年間で2倍以上に増加しています。米国におけるSBSの有病率は1,000万人あたり300例でした。

消化器疾患の患者は、診断検査を受ける前に絶食を求められるため、栄養悪化のリスクが高いです。また、治療による食事制限、食欲不振による食欲減退、または疾患自体の結果となりうる栄養要求量の変化により、栄養悪化に直面することもあります。そのため、これらの患者は食物を摂取できないため、医療栄養が推奨されます。必要な栄養素を補給するには、経腸栄養剤経路が望ましいです。経腸栄養剤とは、口から、または消化管（口から胃/小腸、そして肛門）を通過するチューブを通して、食物栄養を直接摂取することを指します。このタイプの栄養補給は、神経疾患、消化器疾患、遺伝性代謝疾患などの慢性疾患を患う患者の治療サポートに好まれています。したがって、胃腸疾患の急増が経腸栄養剤市場の成長を牽引しています。

北米の経腸栄養剤市場の概要

北米の経腸栄養剤市場は米国、カナダ、メキシコに区分されます。北米は、慢性疾患の有病率の上昇、市場参入企業による戦略的開拓の進展、経腸栄養剤への嗜好の高まりにより、大きな市場シェアを占めており、同地域の市場発展に寄与しています。さらに、慢性的な健康状態の治療における経管栄養などの医療栄養の利点に関する個人の知識の急増が、予測期間中の北米の経腸栄養剤市場の成長を後押しすると予想されます。

米国では、がんや心臓病などの慢性疾患が障害や死亡の主な原因となっています。National Center for Chronic Disease Prevention and Health Promotionによると、米国では10人に6人が少なくとも1つの慢性疾患を抱えています。さらに、米国病院協会の推計によると、1億3,300万人が少なくとも1つの慢性疾患を持っており、その数は2030年までに1億7,000万人に達すると予想されています。経腸経管栄養は、小児の350以上の疾患の治療に処方することができます。

北米の経腸栄養剤市場の収益と2030年までの予測（金額）

北米の経腸栄養剤市場のセグメンテーション

北米の経腸栄養剤市場は、製品タイプ、用途、年齢層、流通チャネル、国によって区分されます。

製品タイプ別では、北米の経腸栄養剤市場は一般的なものと疾患特異的なものに二分されます。2022年の北米の経腸栄養剤市場は、一般セグメントが大きなシェアを占めています。

用途別では、北米の経腸栄養剤市場は胃腸障害、代謝/先天性代謝異常、食物アレルギー、腎臓病、肝臓病、腫瘍学、神経学、その他に区分されます。胃腸障害セグメントは2022年に北米の経腸栄養剤市場最大のシェアを占めました。

年齢層別では、北米の経腸栄養剤市場は成人と小児に二分されます。成人セグメントは2022年に北米の経腸栄養剤市場シェアでより大きな割合を占めました。

流通チャネル別では、北米の経腸栄養剤市場は病院薬局、小売店、eコマース、その他に区分されます。2022年の北米の経腸栄養剤剤市場シェアは病院薬局セグメントが最大でした。

国別では、北米の経腸栄養剤市場は米国、カナダ、メキシコに分類されます。米国が2022年の北米の経腸栄養剤市場を独占しました。

Abbott Laboratories社、Nestle SA社、Danone SA社、Fresenius SE &Co KGaA社、B Braun SE社、Dr Schar AG社、Reckitt Benckiser Group Plc社、Nutritional Medicinals LLC社、Kate Farms Inc社、Royal FrieslandCampina NV社、Arla Foods amba社、Perrigo Co Plc社、Fonterra Co-Operative Group Ltd社は、北米の経腸栄養剤剤市場で事業展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の経腸栄養剤市場：主要産業力学

  • 主な市場促進要因
    • 胃腸疾患の有病率の増加
    • 栄養不良および早産事例の増加
  • 市場抑制要因
    • 経腸栄養剤システムに関連する合併症
  • 市場機会
    • 主要市場企業の戦略的取り組み
  • 今後の動向
    • 特定の処方と植物ベースの栄養製品
  • 影響分析

第5章 経腸栄養剤市場 - 北米市場分析

  • 北米の経腸栄養剤市場の収益（2022年～2030年）

第6章 北米の経腸栄養剤市場 - 2030年までの収益と予測：製品タイプ別

  • 北米の経腸栄養剤剤市場の収益シェア：製品タイプ別（2022年・2030年）
  • 一般
  • 疾患別

第7章 北米の経腸栄養剤市場 - 2030年までの収益と予測：用途別

  • 北米の経腸栄養剤剤市場の収益シェア：用途別（2022年・2030年）
  • 胃腸障害
  • 代謝/先天性代謝異常
  • アレルギー
  • 腎疾患
  • 肝臓疾患
  • 腫瘍学
  • 神経学
  • その他

第8章 北米の経腸栄養剤市場 - 2030年までの収益と予測：年齢層別

  • 北米の経腸栄養剤剤市場の収益シェア：年齢層別（2022年・2030年）
  • 成人
  • 小児

第9章 北米の経腸栄養剤剤市場 - 2030年までの収益と予測：流通チャネル別

  • 北米の経腸栄養剤剤市場の収益シェア：流通チャネル別（2022年・2030年）
  • 病院薬局
  • 小売店
  • eコマース
  • その他

第10章 北米の経腸栄養剤市場：国別分析

  • 米国
  • カナダ
  • メキシコ

第11章 経腸栄養剤市場：業界情勢

  • 経腸栄養剤市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Nestle SA
  • Danone SA
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Dr Schar AG
  • Reckitt Benckiser Group Plc
  • Nutritional Medicinals LLC
  • Kate Farms Inc
  • Royal FrieslandCampina NV
  • Arla Foods amba
  • Perrigo Co Plc
  • Fonterra Co-Operative Group Ltd

第13章 付録

図表

List Of Tables

  • Table 1. North America Enteral Nutrition Market Segmentation
  • Table 2. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - General
  • Table 3. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 4. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 5. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 6. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 7. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 8. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 9. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 10. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 11. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 12. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 13. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 14. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 15. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 16. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 17. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 18. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 19. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 20. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 21. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 22. Recent Inorganic Growth Strategies in the Enteral Nutrition Market
  • Table 23. Recent Organic Growth Strategies in the Enteral Nutrition Market
  • Table 24. Glossary of Terms, Enteral Nutrition Market

List Of Figures

  • Figure 1. North America Enteral Nutrition Market Segmentation, By Country
  • Figure 2. North America Enteral Nutrition Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Enteral Nutrition Market Revenue (US$ million), 2020 - 2030
  • Figure 5. North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • Figure 6. General: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Disease Specific: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 9. Gastrointestinal Disorder: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Allergy: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Renal Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Liver Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Neurology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • Figure 18. Adult: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pediatric: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 21. Hospital Pharmacies: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Enteral Nutrition Market, 2022 (US$ million)
  • Figure 26. North America Enteral Nutrition Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 28. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 29. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 30. Growth Strategies in the Enteral Nutrition Market
目次
Product Code: BMIRE00029862

The North America enteral nutrition market was valued at US$ 3,206.58 million in 2022 and is expected to reach US$ 5,187.48 million by 2030; it is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Increasing Prevalence of Gastrointestinal Diseases Fuel North America Enteral Nutrition Market

Gastrointestinal diseases include Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancer types. As per the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence of SBS was ~300 cases per 10 million in the US.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Thus, medical nutrition is recommended for these patients due to their inability to ingest food. Enteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to the direct intake of food nutrients through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Therefore, the surging prevalence of gastrointestinal diseases drives the growth of the enteral nutrition market.

North America Enteral Nutrition Market Overview

The North America enteral nutrition market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions are anticipated to boost the North America enteral nutrition market growth during the forecast period.

Chronic diseases, such as cancer and heart disease, are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country have at least one chronic disease. Additionally, the American Hospital Association estimates ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

North America Enteral Nutrition Market Segmentation

The North America enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the North America enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger North America enteral nutrition market share in 2022.

In terms of application, the North America enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest North America enteral nutrition market share in 2022.

Based on age group, the North America enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger North America enteral nutrition market share in 2022.

By distribution channel, the North America enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest North America enteral nutrition market share in 2022.

Based on country, the North America enteral nutrition market is categorized into the US, Canada, and Mexico. The US dominated the North America enteral nutrition market in 2022.

Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Dr Schar AG, Reckitt Benckiser Group Plc, Nutritional Medicinals LLC, Kate Farms Inc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the North America enteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Enteral Nutrition Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Gastrointestinal Diseases
    • 4.1.2 Rising Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Complications Associated with Enteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 4.5 Impact Analysis

5. Enteral Nutrition Market - North America Market Analysis

  • 5.1 North America Enteral Nutrition Market Revenue (US$ million), 2022 - 2030

6. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 6.3 General
    • 6.3.1 Overview
    • 6.3.2 General: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 North America Enteral Nutrition Market, by General
        • 6.3.2.1.1 North America Enteral Nutrition Market, by Elemental Formula
  • 6.4 Disease Specific
    • 6.4.1 Overview
    • 6.4.2 Disease Specific: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Gastrointestinal Disorder
    • 7.3.1 Overview
    • 7.3.2 Gastrointestinal Disorder: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Metabolic/Inborn Errors of Metabolism
    • 7.4.1 Overview
    • 7.4.2 Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Allergy
    • 7.5.1 Overview
    • 7.5.2 Allergy: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Renal Disease
    • 7.6.1 Overview
    • 7.6.2 Renal Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Liver Disease
    • 7.7.1 Overview
    • 7.7.2 Liver Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Oncology
    • 7.8.1 Overview
    • 7.8.2 Oncology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Neurology
    • 7.9.1 Overview
    • 7.9.2 Neurology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group

  • 8.1 Overview
  • 8.2 North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • 8.3 Adult
    • 8.3.1 Overview
    • 8.3.2 Adult: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pediatric
    • 8.4.1 Overview
    • 8.4.2 Pediatric: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Stores
    • 9.4.1 Overview
    • 9.4.2 Retail Stores: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 E-Commerce
    • 9.5.1 Overview
    • 9.5.2 E-Commerce: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Enteral Nutrition Market - Country Analysis

  • 10.1 North America Enteral Nutrition Market, Revenue and Forecast To 2030
    • 10.1.1 North America Enteral Nutrition Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.1.3 US Enteral Nutrition Market, by Product Type
        • 10.1.1.1.3.1 US Enteral Nutrition Market, by General
        • 10.1.1.1.3.1.1 US Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.1.4 US Enteral Nutrition Market, by Application
        • 10.1.1.1.5 US Enteral Nutrition Market, by Age Group
        • 10.1.1.1.6 US Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.2.3 Canada Enteral Nutrition Market, by Product Type
        • 10.1.1.2.3.1 Canada Enteral Nutrition Market, by General
        • 10.1.1.2.3.1.1 Canada Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.2.4 Canada Enteral Nutrition Market, by Application
        • 10.1.1.2.5 Canada Enteral Nutrition Market, by Age Group
        • 10.1.1.2.6 Canada Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.3.3 Mexico Enteral Nutrition Market, by Product Type
        • 10.1.1.3.3.1 Mexico Enteral Nutrition Market, by General
        • 10.1.1.3.3.1.1 Mexico Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.3.4 Mexico Enteral Nutrition Market, by Application
        • 10.1.1.3.5 Mexico Enteral Nutrition Market, by Age Group
        • 10.1.1.3.6 Mexico Enteral Nutrition Market, by Distribution Channel

11. Enteral Nutrition Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Enteral Nutrition Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Nestle SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danone SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Fresenius SE & Co KGaA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 B Braun SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Dr Schar AG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Reckitt Benckiser Group Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nutritional Medicinals LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Kate Farms Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Royal FrieslandCampina NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Arla Foods amba
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Perrigo Co Plc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Fonterra Co-Operative Group Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms